Clinical study on safety assessment of PRP therapy for iliopsoas impingement after total hip arthroplasty(PRP for illiopsoas impingement)

Phase 1

• Conditions: Patients who is diagnosed iliopsoas impingement after total hip arthroplasty

• Registration Number: JPRN-jRCTb030190272
• Lead Sponsor: Homma Yasuhiro

Brief Summary

Safety of PRP for psoasimpingement after total hip arthroplasty was demosntrated.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-31
• Study Completion: 2021-01-20
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 3

Inclusion Criteria

1.Patients who have symptoms for more than 3 months
2.Patients who have continued pain even after taking NSAIDs for 6 week or more and who can not use NSAIDs for asthma and digestive tract ulcer
3. More than 20 years old
4. Other , patients who the doctor has determined that it is suitable for this clinicalstudy

Exclusion Criteria

1. Patients with abnormal platelet counts in peripheral blood
2. Person who smokes a lot(Brinkmanindex>600)
3. Treatment with anticoagulants(Warfarin)
4. Uncontrolled diabetes mellitus :HbA1c not lower than 9.0% according to latest laboratory data obtained within 14 days before registration
5. Patients with malignancy
6. Patients less than 6 months after onset of cardiac infarction or cerebral infarction
7. Predictive survival period is less than 1 year
8.Active infectious disease (HBV, HCV, HTLV-1, HIV, syphilis)
9.Dialysis patients
10. Compromised host
11. Requiring continued use of oral corticosteroid therapy
12. Less than 20 years old
13. Doctor has determined that it is not suitable for this clinical study

Study & Design

• Study Type: Interventional
• Study Design: Not specified